Skip to main content
. Author manuscript; available in PMC: 2010 May 18.
Published in final edited form as: Leukemia. 2008 Sep 25;22(12):2142–2150. doi: 10.1038/leu.2008.251

Figure 2. Kaplan-Meier estimates of survival after relapse for patients stratified by NCI risk group at diagnosis and timing of relapse.

Figure 2

There were significant differences in outcome for those SR versus HR patients experiencing either an early (33.1±3.6% vs 14.9±2.1%, p<0.0001), intermediate (52.2±3.7% vs 22.0±3.9%, p<0.0001) or late relapse (59.6±4.6% vs 39.5±7.2%, p< 0.0001)).